Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

16.13p
   
  • Change Today:
    -0.13p
  • 52 Week High: 48.10
  • 52 Week Low: 15.70
  • Currency: UK Pounds
  • Shares Issued: 412.15m
  • Volume: 519,832
  • Market Cap: £66.46m
  • Beta: 0.28

Latest ShareCast News

Creo Medical extends closing date for retail offer

By Josh White

Date: Friday 04 Oct 2024

(Sharecast News) - Creo Medical Group announced an extension to the closing date for its retail offer on Friday, allowing existing retail shareholders more time to participate.

Creo Medical reports year of solid progress

By Josh White

Date: Wednesday 26 Jun 2024

(Sharecast News) - Surgical endoscopy medical device specialist Creo Medical Group reported solid progress over the last 12 months in an update on Wednesday, as it leveraged funds from the March 2023 equity raise to advance its strategic goals.

Creo device used in 'groundbreaking' lung cancer procedure

By Josh White

Date: Friday 01 Mar 2024

(Sharecast News) - Creo Medical Group announced a significant milestone in the field of minimally-invasive surgical endoscopy for cancer patients on Friday, with its 'MicroBlate Flex' device.

Creo Medical FY revenues up double digits 07-Feb-2024 ShareCast
Creo launches 'Speedboat Ultraslim' with first U... 13-Dec-2023 ShareCast
Creo Medical gets US FDA clearance for Speedboat... 01-Nov-2023 ShareCast
Creo Medical accelerating EU launch of Speedboat... 25-Oct-2023 ShareCast
Creo Medical's 'Speedboat Inject' used for first... 26-Jun-2023 ShareCast
Creo's Speedboat Inject to be evaluated by NICE 01-Jun-2023 ShareCast
Creo Medical achieves second Albyn earn-out target 14-Apr-2023 ShareCast
Creo raising at least £25m to progress various p... 16-Feb-2023 ShareCast
Creo Medical signs IP licence deal with CMR Surg... 24-Oct-2022 ShareCast
Creo Medical ends year with revenue above foreca... 03-Feb-2022 ShareCast
Creo Medical acquires Aber Electronics for undis... 12-Nov-2021 ShareCast
Creo Medical losses widen slightly as products p... 30-Sep-2021 ShareCast
Creo Medical opens new US headquarters as it foc... 16-Jul-2021 ShareCast
Creo Medical buys freehold on head office and ad... 06-Jul-2021 ShareCast
Creo upbeat on first in-human use of MicroBlate ... 16-Jun-2021 ShareCast
Creo Medical buying freehold of current Chepstow... 14-Jun-2021 ShareCast
Creo sales grow, losses widen as company expands 04-Jun-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 16.13p
Change Today -0.13p
% Change -0.77 %
52 Week High 48.10
52 Week Low 15.70
Volume 519,832
Shares Issued 412.15m
Market Cap £66.46m
Beta 0.28

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
9.49% above the market average9.49% above the market average9.49% above the market average9.49% above the market average9.49% above the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average
Price Trend
84.46% below the market average84.46% below the market average84.46% below the market average84.46% below the market average84.46% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average
Income Not Available
Growth
24.41% above the market average24.41% above the market average24.41% above the market average24.41% above the market average24.41% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:20 20,343 @ 16.12p
16:10 3,206 @ 16.15p
14:56 234 @ 16.24p
14:45 19,868 @ 16.12p
13:59 38,584 @ 16.12p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page